Incidence of airflow limitation in subjects 65-100 years of age

European Respiratory Journal

Volumn 47, Issue 2, 2016, Pages 461-472

  Luoto, Johannes A ^a   Elmståhl, Sölve ^a   Wollmer, Per ^a   Pihlsgård, Mats ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRFLOW LIMITATION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INCIDENCE; LOWER LIMIT OF NORMAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS; SEX DIFFERENCE; SMOKING HABIT; SPIROMETRY; VERY ELDERLY; AGE; COHORT ANALYSIS; LONGITUDINAL STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SWEDEN; VITAL CAPACITY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; SMOKING; SPIROMETRY; SWEDEN; VITAL CAPACITY;

EID: 84958087450     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00635-2015     Document Type: Article

References (35)

1. Rycroft C, Heyes A, Lanza L, et al. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 2012; 7: 457.
2. Lindberg A, Jonsson A-C, Rönmark E, et al. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005; 127: 1544-1552.
3. Lindberg A, Eriksson B, Larsson LG, et al. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 2006; 129: 879-885.
4. Kojima S, Sakakibara H, Motani S, et al. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. J Epidemiol 2007; 17: 54-60.
5. de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007; 175: 32-39.
6. Johannessen A, Omenaas E, Bakke P, et al. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005; 9: 926-932.
7. Løkke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935-939.
8. Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002; 166: 329-332.
9. Omori H, Nagano M, Funakoshi Y, et al. Twelve-year cumulative incidence of airflow obstruction among Japanese males. Intern Med 2011; 50: 1537-1544.
10. de Marco R, Accordini S, Marcon A, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med 2011; 183: 891-897.
11. Mohamed Hoesein FAA, Zanen P, Lammers J-WJ. Lower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011; 105: 907-915.
12. Medbø A, Melbye H. Lung function testing in the elderly - can we still use FEV1/FVC<70% as a criterion of COPD? Respir Med 2007; 101: 1097-1105.
13. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
14. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117-1122.
15. Wollmer P, Engström G. Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study. Respir Med 2013; 107: 1460-1462.
16. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. www.goldcopd.org Date last accessed: June 15, 2015. Date last updated: January 2015.
17. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
18. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
19. Stenhagen M, Ekström H, Nordell E, et al. Falls in the general elderly population: a 3- and 6-year prospective study of risk factors using data from the longitudinal population study "Good ageing in Skane". BMC Geriatr 2013; 13: 81.
20. Ekström H, Elmståhl S. Pain and fractures are independently related to lower walking speed and grip strength: results from the population study "Good Ageing in Skåne". Acta Orthop 2006; 77: 902-911.
21. Lagergren M, Fratiglioni L, Hallberg IR, et al. A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC). Aging Clin Exp Res 2004; 16: 158-168.
22. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
23. Quanjer PH, Stanojevic S, Cole TJ, et al. Implementing GLI-2012 regression equations. Global Lung Function Initiative. www.ers-education.org/media/media.aspx?idmedia=266709 Date last accessed: June 15, 2015.
24. Kainu A, Lindqvist A, Sarna S, et al. FEV1 response to bronchodilation in an adult urban population. Chest 2008; 134: 387-393.
25. Turkeshi E, Vaes B, Andreeva E, et al. Airflow limitation by the Global Lungs Initiative equations in a cohort of very old adults. Eur Respir J 2015; 46: 123-132.
26. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 446-451.
27. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999; 54: 1119-1138.
28. Kanner RE, Connett JE, Altose MD, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 1994; 150: 956-961.
29. Dransfield MT, Washko GR, Foreman MG, et al. Gender differences in the severity of CT emphysema in COPD. Chest 2007; 132: 464-470.
30. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
31. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620.
32. Bergdahl IA, Torén K, Eriksson K, et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J 2004; 23: 402-406.
33. Bakke PS, Hanoa R, Gulsvik A. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am J Epidemiol 1995; 141: 1080-1088.
34. Prescott E, Vestbo J. Socioeconomic status and chronic obstructive pulmonary disease. Thorax 1999; 54: 737-741.
35. Schikowski T, Mills IC, Anderson HR, et al. Ambient air pollution: a cause of COPD? Eur Respir J 2014; 43: 250-263.